Pressetexte | Biotez Berlin

04 Jan 2022

BBI Solutions …

BBI Solutions completes Acquisition of BioTeZ Berlin-Buch GmbH and Steffens Biotechnische Analysen GmbH! Read more

ahnert

20 Okt 2021

SARS-CoV-2 related Proteins

Rechtzeitig zur MEDICA 2021 unterstützt BioTeZ Diagnostik Hersteller mit neuen rekombinanten Proteinen für spezifische und sensitive COVID 19 Tests. Dazu gehören: Recombinant SARS-CoV-2 Nucleocapsid Protein full length, His-tagged (PODTC9) NC_045512.2;…

ahnert

Pressetexte, Uncategorized

05 Mai 2021

New Protein from BioTeZ: Recombinant SARS-CoV-2 Nucleocapsid Protein full length, His-tagged, free of nucleic acid

SARS-CoV-2 Nucleocapsid protein is the main structural protein of SARS-associated coronavirus (CoV) that binds the viral RNA genome. It is a recombinant protein, expressed in E.coli cells. The protein consists…

ahnert

Pressetexte

09 Mai 2019

BioTeZ established a novel surface functionalization kit -the TA-PAS system.

The strong interaction between streptavidin and biotin is widely utilized in biotechnological applications (1). The new TAPAS label was developed to extend the portfolio for assay manufactured and will be valuable for…

ahnert